HK1137623A1 - Methods of treating neuronal disorders using mntf peptides and analogs thereof mntf - Google Patents

Methods of treating neuronal disorders using mntf peptides and analogs thereof mntf

Info

Publication number
HK1137623A1
HK1137623A1 HK10102626.6A HK10102626A HK1137623A1 HK 1137623 A1 HK1137623 A1 HK 1137623A1 HK 10102626 A HK10102626 A HK 10102626A HK 1137623 A1 HK1137623 A1 HK 1137623A1
Authority
HK
Hong Kong
Prior art keywords
mntf
analogs
methods
peptides
neuronal disorders
Prior art date
Application number
HK10102626.6A
Other languages
English (en)
Chinese (zh)
Inventor
‧寇
‧金迪
Original Assignee
健能萬生物製藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健能萬生物製藥公司 filed Critical 健能萬生物製藥公司
Publication of HK1137623A1 publication Critical patent/HK1137623A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK10102626.6A 2006-11-10 2010-03-12 Methods of treating neuronal disorders using mntf peptides and analogs thereof mntf HK1137623A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85802206P 2006-11-10 2006-11-10
PCT/US2007/023951 WO2008057609A2 (en) 2006-11-10 2007-11-13 Methods of treating neuronal disorders using mntf peptides and analogs thereof

Publications (1)

Publication Number Publication Date
HK1137623A1 true HK1137623A1 (en) 2010-08-06

Family

ID=39365151

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10102626.6A HK1137623A1 (en) 2006-11-10 2010-03-12 Methods of treating neuronal disorders using mntf peptides and analogs thereof mntf

Country Status (10)

Country Link
US (1) US8673852B2 (da)
EP (1) EP2086331B1 (da)
JP (1) JP5336384B2 (da)
CN (1) CN101534648B (da)
AU (1) AU2007317730B2 (da)
CA (1) CA2669658C (da)
DK (1) DK2086331T3 (da)
ES (1) ES2407454T3 (da)
HK (1) HK1137623A1 (da)
WO (1) WO2008057609A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105780A2 (en) * 2008-02-21 2009-08-27 Genervon Biopharmaceuticals Llc Mntf peptide compositions and methods of use
CN102762589A (zh) * 2009-12-11 2012-10-31 卡斯西部储备大学 带有氯化氨基酸的胰岛素类似物
GB201015569D0 (en) * 2010-09-16 2010-10-27 Medical Res Council Blood assay for prions
WO2016210123A1 (en) 2015-06-26 2016-12-29 Genervon Biopharmaceuticals, LLC Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease
JP2020515813A (ja) * 2016-12-23 2020-05-28 ジェナボン バイオファーマシューティカルズ エルエルシー アルツハイマー病の診断および治療においてｇｍ６を使用する方法
WO2018129421A1 (en) * 2017-01-09 2018-07-12 Genervon Biopharmaceuticals, LLC A promising drug candidate for parkinson's disease
WO2019229757A1 (en) * 2018-05-31 2019-12-05 Immunity Pharma Ltd. Compositions and methods of using same for treating amyotrophic lateral sclerosis (als)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841531B2 (en) * 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
US6309877B1 (en) * 1996-09-27 2001-10-30 Km Biotech, Inc. Polynucleotides encoding motoneuronotrophic factors
CA2506855C (en) * 2003-01-21 2013-08-27 Genervon Biopharmaceuticals Llc Mntf peptides and compositions and methods of use

Also Published As

Publication number Publication date
WO2008057609A3 (en) 2008-12-18
WO2008057609A2 (en) 2008-05-15
CN101534648A (zh) 2009-09-16
EP2086331A2 (en) 2009-08-12
AU2007317730A1 (en) 2008-05-15
JP5336384B2 (ja) 2013-11-06
AU2007317730B2 (en) 2014-01-09
US20090048162A1 (en) 2009-02-19
ES2407454T3 (es) 2013-06-12
US8673852B2 (en) 2014-03-18
WO2008057609A8 (en) 2008-08-28
WO2008057609A4 (en) 2009-01-29
CN101534648B (zh) 2013-12-11
CA2669658A1 (en) 2008-05-15
JP2010509345A (ja) 2010-03-25
DK2086331T3 (da) 2013-05-27
CA2669658C (en) 2017-12-12
EP2086331A4 (en) 2010-08-25
EP2086331B1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
EP1981526A4 (en) ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
IL202611A0 (en) Methods of treating serotonin-mediated diseases and disorders
ZA200900051B (en) Modulators of metabolism and the treatment of disorders related thereto
IL195851A0 (en) Modulators of metabolism and the treatment of disorders related thereto
SI2374472T1 (sl) Sestavki in postopki za zdravljenje oftalmoloških motenj
GB0617734D0 (en) Method of treating peripheral nerve disorders
IL204743A0 (en) Inhibition of macrophage - stimulating protein receptor (ron) and methods of treatment thereof
EP2268140A4 (en) NOVEL COMPOUNDS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM
IL193747A0 (en) New therapeutic combinations for the treatment of depression
HK1137623A1 (en) Methods of treating neuronal disorders using mntf peptides and analogs thereof mntf
PL2061501T3 (pl) Sposób leczenia zaburzeń oddechowych
ZA201003497B (en) Methods for treating obesity and obesity related diseases and disorders
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP1996218A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
IL211459A0 (en) Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders
IL193697A0 (en) Methods for treating cognitive and other disorders
EP2077838A4 (en) METHODS FOR TREATING A-RELATED DISORDERS AND COMPOSITIONS THEREFOR
PL2012814T3 (pl) Sposoby leczenia chorób autoimmunologicznych
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
EP2007790A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
IL206435A0 (en) Therapeutic regimens for the treatment of immunoinflammatory disorders
ZA200903653B (en) Methods for treatment of cochlear and vestibular disorders
PT2227246E (pt) Tratamento de fibroses e distúrbios hepáticos
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211117